In CML cells, S116836 inhibited the cell viability of KBM5 harboring BCR-ABL and KBM5-T315I in a dose-dependent fashion with IC50 values of 15.73-407.96 nM [26]. Here, BCR is linked to chronic myelogenous leukemia, BCR-ABL1 positive.